Archives: Month: April 2026

Encouraging Update from the LORD Clinical Trial on Active Surveillance for Low-Risk DCIS

At the recent 15th European Breast Cancer Conference (EBCC15), researchers shared encouraging early findings from the LORD (LOw Risk DCIS) clinical trial , a major international study exploring whether some people diagnosed with low-risk ductal carcinoma in situ (DCIS) can safely avoid immediate surgery.

Read more